Literature DB >> 26684590

Knowns and unknowns of influenza B viruses.

Marios Koutsakos1, Thi H O Nguyen1, Wendy S Barclay2, Katherine Kedzierska1.   

Abstract

Influenza B viruses (IBVs) circulate annually along with influenza A (IAV) strains during seasonal epidemics. IBV can dominate influenza seasons and cause severe disease, particularly in children and adolescents. Research has revealed interesting aspects of IBV and highlighted the importance of these viruses in clinical settings. Yet, many important questions remain unanswered. In this review, the clinical relevance of IBV is emphasized, unique features in epidemiology, host range and virology are highlighted and gaps in knowledge pinpointed. Multiple aspects of IBV epidemiology, evolution, virology and immunology are discussed. Future research into IBV is needed to understand how we can prevent severe disease in high-risk groups, especially children and elderly.

Entities:  

Keywords:  epidemiology; immunology; influenza B; virology

Mesh:

Year:  2015        PMID: 26684590     DOI: 10.2217/fmb.15.120

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  40 in total

1.  Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.

Authors:  Yanmei Hu; Jiantao Zhang; Rami Ghassan Musharrafieh; Chunlong Ma; Raymond Hau; Jun Wang
Journal:  Antiviral Res       Date:  2017-08-02       Impact factor: 5.970

2.  Development and Characterization of a Reverse-Genetics System for Influenza D Virus.

Authors:  Jieshi Yu; Runxia Liu; Bin Zhou; Tsui-Wen Chou; Elodie Ghedin; Zizhang Sheng; Rongyuan Gao; Shao-Lun Zhai; Dan Wang; Feng Li
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

3.  TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.

Authors:  Hannah Limburg; Anne Harbig; Dorothea Bestle; David A Stein; Hong M Moulton; Julia Jaeger; Harshavardhan Janga; Kornelia Hardes; Janine Koepke; Leon Schulte; Andreas Rembert Koczulla; Bernd Schmeck; Hans-Dieter Klenk; Eva Böttcher-Friebertshäuser
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of an Anti-Influenza B Virus Monoclonal Antibody, MHAB5553A, in Healthy Volunteers.

Authors:  Jeremy J Lim; Michael A Derby; Yaping Zhang; Rong Deng; Richard Larouche; Malia Anderson; Mauricio Maia; Stéphanie Carrier; Isabelle Pelletier; Johanne Girard; Priya Kulkarni; Elizabeth Newton; Jorge A Tavel
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  Hemagglutinin Cleavability, Acid Stability, and Temperature Dependence Optimize Influenza B Virus for Replication in Human Airways.

Authors:  Manon Laporte; Annelies Stevaert; Valerie Raeymaekers; Talitha Boogaerts; Inga Nehlmeier; Winston Chiu; Mohammed Benkheil; Bart Vanaudenaerde; Stefan Pöhlmann; Lieve Naesens
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

6.  Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways.

Authors:  Anne Harbig; Marco Mernberger; Linda Bittel; Stephan Pleschka; Klaus Schughart; Torsten Steinmetzer; Thorsten Stiewe; Andrea Nist; Eva Böttcher-Friebertshäuser
Journal:  J Biol Chem       Date:  2020-04-17       Impact factor: 5.157

7.  Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.

Authors:  Megan E Ermler; Ericka Kirkpatrick; Weina Sun; Rong Hai; Fatima Amanat; Veronika Chromikova; Peter Palese; Florian Krammer
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

8.  [Analysis of influenza types and subtypes according to pediatric age in the last four epidemic seasons].

Authors:  J Reina; J Dueñas
Journal:  Rev Esp Quimioter       Date:  2020-03-10       Impact factor: 1.553

9.  Protonation equilibria and pore-opening structure of the dual-histidine influenza B virus M2 transmembrane proton channel from solid-state NMR.

Authors:  Jonathan K Williams; Alexander A Shcherbakov; Jun Wang; Mei Hong
Journal:  J Biol Chem       Date:  2017-09-11       Impact factor: 5.157

10.  Solid-State NMR Investigation of the Conformation, Proton Conduction, and Hydration of the Influenza B Virus M2 Transmembrane Proton Channel.

Authors:  Jonathan K Williams; Daniel Tietze; Myungwoon Lee; Jun Wang; Mei Hong
Journal:  J Am Chem Soc       Date:  2016-06-23       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.